TMPRSS2 and prostate adenocarcinoma: Altogether, even though high expression of TMPRSS2 may not be favourable for PRAD patient's survival, increased TMPRSS2 expression in these patients should play a role in susceptibility for the SARS‐CoV‐2 viral infection and clinical severity for COVID‐19 symptoms.